| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bed3bafe05547f7f822d749f79966fa |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2015-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_826a7a5acd268acf6b6db1ce9e00be03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02338f19ae1a39cd0595a89bfd9dfff9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ae90e06d7a0e31bb0a505c7214963b |
| publicationDate |
2017-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CY-1116617-T1 |
| titleOfInvention |
2,3-DIMETHOXY-5-METHYL-6- (10-Hydroxydykyl) -1,4-Benzoquinone Quinone Derivative for the Treatment of Primary Sclera |
| abstract |
The present invention relates to medicinal products and their uses in the treatment or prevention of primary progressive multiple sclerosis (PP-MS), using 2,3-dimethoxy-5-methyl-6- (10-hydroxydecyl). 1,4-benzoquinone (idebenone) as an active agent. |
| priorityDate |
2009-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |